Côd QR

Efficacy and Safety of Crisaborole Ointment 2% in Chinese Patients Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis

Abstract Introduction Atopic dermatitis (AD) is a chronic immuno-inflammatory skin disease. Crisaborole ointment, 2%, is a nonsteroidal phosphodiesterase 4 inhibitor approved for the treatment of mild to moderate AD. This post hoc analysis assesses the efficacy and safety of crisaborole in Chinese p...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Lin Ma, Xiaohua Tao, Sujun Liu, Hao Cheng, Ruihua Fang, Yan Zhao, Amy Cha, Gerardo A. Encinas, Yangmei Zhou, Yujie Deng, Jianzhong Zhang
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Adis, Springer Healthcare 2024-05-01
Cyfres:Dermatology and Therapy
Pynciau:
Atopic dermatitis
Chinese patients
Crisaborole
Eczema Area and Severity Index
Infant
Phosphodiesterase 4 inhibitors
Mynediad Ar-lein:https://doi.org/10.1007/s13555-024-01156-6
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg